Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy.
May LT, Patel K, García D, Ndubuisi MI, Ferrone S, Mittelman A, Mackiewicz A, Sehgal PB. Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy. Blood. 1994 Sep 15; 84(6):1887-95.